Vaxcyte, Inc.

NASDAQ:PCVX

116.54 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0014.4460000000000000000000
Kosten van de omzet 3.4783.0912.9482.482.4012.3422.32.3542.1642.3691.2060.8460.8680.52700000000
Brutowinst -3.478-3.09111.498-2.48-2.401-2.342-2.3-2.354-2.164-2.369-1.206-0.846-0.868-0.52700000000
Brutowinstmarge 000.7960000000000000000000
Onderzoek- en ontwikkelingskosten 131.50794.587104.1597.42172.69158.0851.62647.67938.46931.67823.07420.42817.65117.25814.66116.4118.17824.31513.3829.639.96812.628
Algemene en administratieve kosten 21.47419.88517.52615.60514.45613.11211.95210.8989.4177.5436.7726.5236.0795.8854.7924.8983.0463.2812.4572.512.2641.316
Verkoop- en marketingkosten -3.4780-2.9480000000000000000000
Verkoop-, algemene en administratieve kosten 17.99619.88514.57815.60514.45613.11211.95210.8989.4177.5436.7726.5236.0795.8854.7924.8983.0463.2812.4572.512.2641.316
Overige kosten 0075.65400-0.654-0.925-0.157-0.69-0.16-0.908-0.299-0.378000000.6650.8441.450.226
Bedrijfskosten 149.503114.346118.728113.02684.68370.53862.65358.4247.19639.06128.93826.65223.35223.14319.12720.52120.18827.26715.65612.08612.23213.944
Bedrijfsresultaat -152.981-114.472-121.676-113.026-87.147-71.192-86.573-58.577-47.886-39.221-29.846-26.951-23.73-23.143-19.453-21.308-21.224-27.596-15.839-12.14-12.232-13.944
Bedrijfsresultaat ratio 00-8.4230000000000000000000
Totaal overige inkomsten en kosten netto 24.278-2.34-59.12520.362-0.10710.738.5230.66-0.6460.2350.276-0.053-0.4131.862-1.642-0.53-0.176-0.0030.9470.6581.3970.05
Inkomen voor belasting -128.703-95.02-180.801-92.664-68.339-60.462-78.05-57.917-48.532-38.986-28.563-26.615-23.679-21.22-20.737-21.018-20.32-27.142-14.621-11.317-10.665-13.671
Inkomen voor belasting ratio 00-12.5160000000000000000000
Belastingkosten 0-19.32614.581-2.482.279-12.10115.397-0.660.646-0.23500.010.0070-0.332-0.33400.0070.6720.8531.4610.239
Nettowinst -128.703-95.02-180.801-92.664-68.339-48.361-93.447-57.257-49.178-38.751-28.563-26.615-23.679-21.22-20.737-21.018-20.32-27.142-14.621-11.317-10.665-13.671
Nettowinstmarge 00-12.5160000000000000000000
WPA (Winst Per Aandeel) -1.1-0.85-1.9-0.91-0.7-0.56-1.23-0.92-0.81-0.67-0.55-0.51-0.46-0.41-0.41-0.41-1.72-0.58-0.57-0.44-0.42-0.53
Verwaterde WPA -1.1-0.85-1.9-0.91-0.7-0.56-1.23-0.92-0.81-0.67-0.55-0.51-0.46-0.41-0.41-0.41-1.72-0.58-0.57-0.44-0.42-0.53
EBITDA -149.503-108.915-118.728-113.026-65.831-70.221-53.72-57.23-44.624-36.633-27.633-25.706-22.391-22.555-19.095-20.488-19.789-26.748-14.564-10.818-10.299-13.188
EBITDA ratio 00-8.2190000000000000000000